AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36203828 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based transcranial direct current stimulation (tDCS) self-administered daily for 30 min with 2 mA
Number of subjects: 64
Study 36203828 — intervention group
Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 64
Study 35454326 — intervention group
Group type: EXPERIMENTAL
Intervention: Co‐analgetic group (Co‐A) with systemic ketamine and lidocaine
Number of subjects: 80
Study 35454326 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural group (EA) with epidural analgesia
Number of subjects: 80
Study 35454326 — intervention group
Group type: COMPARATOR
Intervention: Standard group (C) with perioperative opioids and metamizole/acetaminophen
Number of subjects: 80
Study 35377106 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled lavender essential oil (LEO)
Number of subjects: 142
Study 35377106 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care with swaddling, oral sucrose, and sucking)
Number of subjects: 142
Study 33026901 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoselective vaporization of the prostate
Number of subjects: 15982
Study 33026901 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic enucleation
Number of subjects: 15982
Study 33026901 — intervention group
Group type: EXPERIMENTAL
Intervention: Other transurethral procedures
Number of subjects: 15982
Study 33026901 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic enucleation (2011-2012)
Number of subjects: 15982
Study 33026901 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate
Number of subjects: 15982
Study 33038825 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (200 mg/kg)
Number of subjects: 240
Study 33038825 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine (2 g/kg)
Number of subjects: 240
Study 33038825 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Ascorbic acid (200 mg/kg) and Betaine (2 g/kg)
Number of subjects: 240
Study 33038825 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet only)
Number of subjects: 240
Study 33836458 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Hz local vibration
Number of subjects: 27
Study 33836458 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 Hz local vibration
Number of subjects: 27
Study 33836458 — intervention group
Group type: COMPARATOR
Intervention: Control group (exercise)
Number of subjects: 27
Study 32945150 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine
Number of subjects: 674
Study 32945150 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 674
Study 36103158 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 100 mg/d
Number of subjects: 149
Study 36103158 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg/d
Number of subjects: 149
Study 36103158 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 400 mg/d
Number of subjects: 149
Study 36103158 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 149
Study 34312921 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 ml/kg 5% Dextrose
Number of subjects: 44
Study 34312921 — intervention group
Group type: COMPARATOR
Intervention: 5 ml/kg 5% Dextrose
Number of subjects: 44
Study 37675488 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg daily
Number of subjects: 32
Study 37675488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 35074540 — intervention group
Group type: EXPERIMENTAL
Intervention: ABCDEF pulmonary rehabilitation program
Number of subjects: 90
Study 35074540 — intervention group
Group type: COMPARATOR
Intervention: Regular care (control group)
Number of subjects: 90
Study 33389390 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion coaching parenting intervention (Tuning in to Kids® program), 6 weekly sessions
Number of subjects: 89
Study 33389390 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 89
Study 34627259 — intervention group
Group type: EXPERIMENTAL
Intervention: Care pathways for symptom management
Number of subjects: 23
Study 34627259 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 pandemic impact
Number of subjects: 23
Study 32753268 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban 60 mg
Number of subjects: 2199
Study 32753268 — intervention group
Group type: COMPARATOR
Intervention: Enoxaparin–warfarin
Number of subjects: 2199
Study 34704543 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic cycling
Number of subjects: 5
Study 34704543 — intervention group
Group type: COMPARATOR
Intervention: Active control
Number of subjects: 5
Study 33447376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 2000
Study 33447376 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 2000
Study 33447376 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid recruitment and dissemination
Number of subjects: 2000
Study 33447376 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothetical increased recruitment to 50%
Number of subjects: 2000
Study 34329897 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil (GE) 600 mg
Number of subjects: 0
Study 34329897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34329897 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin enacarbil (GE)
Number of subjects: 0
Study 36344973 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity health education (LIHE)
Number of subjects: 756
Study 36344973 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity health education (HIHE)
Number of subjects: 756
Study 36344973 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-intensity health education (MIHE)
Number of subjects: 756
Study 36344973 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 756
Study 32694214 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin/Saxagliptin (DAPA/SAXA) 10/5 mg
Number of subjects: 56
Study 32694214 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (DAPA) 10 mg
Number of subjects: 56
Study 32694214 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PCB)
Number of subjects: 56
Study 34863853 — intervention group
Group type: EXPERIMENTAL
Intervention: ritlecitinib
Number of subjects: 46
Study 34863853 — intervention group
Group type: EXPERIMENTAL
Intervention: brepocitinib
Number of subjects: 46
Study 34863853 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 46
Study 34776200 — intervention group
Group type: EXPERIMENTAL
Intervention: Core stability training program (3 times a week for 8 weeks)
Number of subjects: 20
Study 32043211 — intervention group
Group type: EXPERIMENTAL
Intervention: UTP (P2Y2R stimulator, 100 μM) and CPA (cryoprotectants)
Number of subjects: 0
Study 32043211 — intervention group
Group type: COMPARATOR
Intervention: Suramin (P2Y2R inhibitor, 100 μM)
Number of subjects: 0
Study 32043211 — intervention group
Group type: EXPERIMENTAL
Intervention: CPA and UTP
Number of subjects: 0
Study 34696892 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib at 160 or 120 mg daily, 3 weeks on/1 week off
Number of subjects: 116
Study 34696892 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen at 40 mg daily
Number of subjects: 116
Study 34696892 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib
Number of subjects: 116
Study 34696892 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 116
Study 33827639 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebiotic (oligofructose‐enriched inulin; 16 g/day)
Number of subjects: 60
Study 33827639 — intervention group
Group type: COMPARATOR
Intervention: Calorie‐matched placebo (maltodextrin)
Number of subjects: 60
Study 33972312 — intervention group
Group type: EXPERIMENTAL
Intervention: MethSig (DNAme driver inference framework)
Number of subjects: 0
Study 33972312 — intervention group
Group type: EXPERIMENTAL
Intervention: CRISPR/Cas9 knockout of selected candidate CLL DNAme drivers
Number of subjects: 0
Study 33972312 — intervention group
Group type: EXPERIMENTAL
Intervention: DNAme driver risk score
Number of subjects: 0
Study 32294559 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT with Bixa orellana extract (20% w/v) and blue LED (395-480 nm)
Number of subjects: 44
Study 32294559 — intervention group
Group type: COMPARATOR
Intervention: Tongue scraping
Number of subjects: 44
Study 32294559 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue scraping and aPDT
Number of subjects: 44
Study 33960497 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group (n=19)
Number of subjects: 59
Study 33960497 — intervention group
Group type: COMPARATOR
Intervention: Completion lymph node dissection group (n=40)
Number of subjects: 59
Study 35672195 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral submental artery island flap (CSIF)
Number of subjects: 64
Study 35672195 — intervention group
Group type: COMPARATOR
Intervention: Primary closure (PC)
Number of subjects: 64
Study 33985385 — intervention group
Group type: EXPERIMENTAL
Intervention: -40 mmHg INP treatment for 1 hour twice daily for 12 weeks
Number of subjects: 61
Study 33985385 — intervention group
Group type: COMPARATOR
Intervention: -10 mmHg INP sham control treatment for 1 hour twice daily for 12 weeks
Number of subjects: 61
Study 33456773 — intervention group
Group type: EXPERIMENTAL
Intervention: PRECLUDE®MVP alone
Number of subjects: 35
Study 33456773 — intervention group
Group type: EXPERIMENTAL
Intervention: PRECLUDE®MVP with autogenous bone graft or titanium mesh
Number of subjects: 35
Study 33118102 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI (Intracytoplasmic Sperm Injection)
Number of subjects: 60
Study 33118102 — intervention group
Group type: COMPARATOR
Intervention: Conventional IVF (In Vitro Fertilization)
Number of subjects: 60
Study 35210509 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive geriatric assessment (CGA)
Number of subjects: 86
Study 33661996 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence‐Related Motivational Engagement (ARME) scale
Number of subjects: 1874
Study 33661996 — intervention group
Group type: EXPERIMENTAL
Intervention: Situation‐specific Abstinence Self‐Efficacy (SSE) scale
Number of subjects: 1874
Study 33661996 — intervention group
Group type: COMPARATOR
Intervention: ARME and SSE measures
Number of subjects: 1874
Study 35139487 — intervention group
Group type: EXPERIMENTAL
Intervention: Da‐Cheng‐Qi Decoction (DCQD)
Number of subjects: 114
Study 35139487 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical treatment
Number of subjects: 114
Study 33840592 — intervention group
Group type: EXPERIMENTAL
Intervention: KFAC and PC with wide phase duration (500 µs)
Number of subjects: 24
Study 33840592 — intervention group
Group type: EXPERIMENTAL
Intervention: KFAC and PC with narrow phase duration (200 µs)
Number of subjects: 24
Study 33840592 — intervention group
Group type: EXPERIMENTAL
Intervention: KFAC and PC with phase duration (500 µs)
Number of subjects: 24
Study 33840592 — intervention group
Group type: EXPERIMENTAL
Intervention: KFAC and PC with phase duration (200 µs)
Number of subjects: 24
Study 36098062 — intervention group
Group type: EXPERIMENTAL
Intervention: Crystalloids
Number of subjects: 80
Study 36098062 — intervention group
Group type: COMPARATOR
Intervention: Colloids
Number of subjects: 80
Study 34071560 — intervention group
Group type: EXPERIMENTAL
Intervention: TEENS+ intervention (individualized dietary goals of 1200-1800 kcal/day)
Number of subjects: 82
Study 34071560 — intervention group
Group type: EXPERIMENTAL
Intervention: TEENS+ intervention
Number of subjects: 82
Study 33210555 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-padded cycling pad
Number of subjects: 183
Study 33210555 — intervention group
Group type: COMPARATOR
Intervention: Full-padded cycling bib shorts
Number of subjects: 183
Study 36484214 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorb bioresorbable scaffold (BRS)
Number of subjects: 120
Study 36484214 — intervention group
Group type: COMPARATOR
Intervention: Xience drug-eluting stent (DES)
Number of subjects: 120
Study 36484214 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BRS and DES)
Number of subjects: 120
Study 33756301 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigalike (18 mg/mL)
Number of subjects: 50
Study 33756301 — intervention group
Group type: EXPERIMENTAL
Intervention: Tank (18 mg/mL)
Number of subjects: 50
Study 33756301 — intervention group
Group type: EXPERIMENTAL
Intervention: Tank (6 mg/mL)
Number of subjects: 50
Study 33196747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.045% lotion
Number of subjects: 1614
Study 33196747 — intervention group
Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 1614
Study 34622734 — intervention group
Group type: EXPERIMENTAL
Intervention: CET + acamprosate
Number of subjects: 0
Study 34622734 — intervention group
Group type: EXPERIMENTAL
Intervention: CET monotherapy
Number of subjects: 0
Study 34622734 — intervention group
Group type: COMPARATOR
Intervention: AAU monotherapy
Number of subjects: 0
Study 34622734 — intervention group
Group type: COMPARATOR
Intervention: AAU + acamprosate
Number of subjects: 0
Study 33242736 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding (starting fluids and soft diet on the day following surgery)
Number of subjects: 200
Study 33242736 — intervention group
Group type: COMPARATOR
Intervention: Late feeding (five-day post-operative period of 'nil by mouth')
Number of subjects: 200
Study 33242736 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 32804950 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi vaccine
Number of subjects: 70566
Study 32804950 — intervention group
Group type: COMPARATOR
Intervention: Control (Hepatitis A vaccine)
Number of subjects: 70566
Study 35386039 — intervention group
Group type: EXPERIMENTAL
Intervention: Women United: Clinical Trials and the Fight Against Breast Cancer Program (intervention group, n=215)
Number of subjects: 422
Study 35386039 — intervention group
Group type: COMPARATOR
Intervention: Control program (control group, n=207)
Number of subjects: 422
Study 33844409 — intervention group
Group type: EXPERIMENTAL
Intervention: ROLLIS
Number of subjects: 123
Study 33844409 — intervention group
Group type: COMPARATOR
Intervention: HWL
Number of subjects: 123
Study 35820713 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel algorithm and software for early detection of acute illness
Number of subjects: 273
Study 34622764 — intervention group
Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg twice daily for 12 weeks, followed by continued treatment through Week 64
Number of subjects: 207
Study 34622764 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207
Study 32414338 — intervention group
Group type: EXPERIMENTAL
Intervention: Management algorithm including extended focused assessment of sonography for HIV and tuberculosis (eFASH) in combination with chest X-ray and microbiological tests.
Number of subjects: 650
Study 32414338 — intervention group
Group type: COMPARATOR
Intervention: National guidelines management (control group).
Number of subjects: 650
Study 35393384 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) plus standard care
Number of subjects: 65
Study 35393384 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 65
Study 34062535 — intervention group
Group type: EXPERIMENTAL
Intervention: HBM-based intervention
Number of subjects: 136
Study 34062535 — intervention group
Group type: COMPARATOR
Intervention: Control group (PR program only)
Number of subjects: 136
Study 33003389 — intervention group
Group type: EXPERIMENTAL
Intervention: Enriched protein drink (protein+)
Number of subjects: 123
Study 33003389 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control drink (control)
Number of subjects: 123
Study 33003389 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (both groups)
Number of subjects: 123
Study 33003389 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (MIR subgroup)
Number of subjects: 123
Study 33003389 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (no-MIR subgroup)
Number of subjects: 123
Study 34974413 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg OD)
Number of subjects: 77
Study 34974413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 33539318 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripterygium glycosides (TG) 20 mg tablet three times per day for 24 weeks
Number of subjects: 161
Study 33539318 — intervention group
Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (iv.MP) 500 mg once per week for 6 weeks followed by 250 mg per week for 6 weeks
Number of subjects: 161
Study 33539318 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripterygium glycosides (TG)
Number of subjects: 161
Study 33539318 — intervention group
Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (iv.MP)
Number of subjects: 161
Study 33235030 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapansutrile 2000 mg
Number of subjects: 30
Study 33235030 — intervention group
Group type: COMPARATOR
Intervention: Dapansutrile (all cohorts)
Number of subjects: 30
Study 35775120 — intervention group
Group type: EXPERIMENTAL
Intervention: Buddy-style intervention (5-10 min once a week for 12 weeks)
Number of subjects: 65
Study 35775120 — intervention group
Group type: COMPARATOR
Intervention: Control group (12-week home-based exercise program without buddy-style intervention)
Number of subjects: 65
Study 35775120 — intervention group
Group type: EXPERIMENTAL
Intervention: Buddy-style intervention
Number of subjects: 65
Study 35775120 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 65
Study 34574458 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM) - Angelicae Sinensis Radix
Number of subjects: 48
Study 34574458 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM) - Astragali Radix
Number of subjects: 48
Study 34574458 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM) - Salviae Miltiorrhizae Radix et Rhizoma
Number of subjects: 48
Study 34574458 — intervention group
Group type: COMPARATOR
Intervention: Control group (other CHM products)
Number of subjects: 48
Study 32815840 — intervention group
Group type: EXPERIMENTAL
Intervention: Volar plate with addition of a dorsal ulnar pin plate
Number of subjects: 18
Study 32815840 — intervention group
Group type: COMPARATOR
Intervention: Volar plate only
Number of subjects: 18
Study 34320853 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored parent education program
Number of subjects: 109
Study 34320853 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 109
Study 34656033 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate (LC) diet
Number of subjects: 48
Study 34656033 — intervention group
Group type: COMPARATOR
Intervention: Calorie-restricted (CR) diet
Number of subjects: 48
Study 35549984 — intervention group
Group type: EXPERIMENTAL
Intervention: Early parenteral nutrition (early-PN)
Number of subjects: 521
Study 35549984 — intervention group
Group type: COMPARATOR
Intervention: Late parenteral nutrition (late-PN)
Number of subjects: 521
Study 32429737 — intervention group
Group type: EXPERIMENTAL
Intervention: Tart Cherry Juice (240 mL, twice daily for 12 weeks)
Number of subjects: 19
Study 32429737 — intervention group
Group type: COMPARATOR
Intervention: Control (isocaloric placebo drink, twice daily for 12 weeks)
Number of subjects: 19
Study 36575506 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL of a clear supplement containing 10 g of whey protein and 54 g of carbohydrates (WP+CHO)
Number of subjects: 0
Study 36575506 — intervention group
Group type: COMPARATOR
Intervention: 200 mL of a clear supplement containing 12.5% maltodextrin (25 g) (CHO)
Number of subjects: 0
Study 36575506 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting period of 8 hours
Number of subjects: 0
Study 33647827 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended cognitive dissonance
Number of subjects: 98
Study 33647827 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard cognitive dissonance
Number of subjects: 98
Study 33647827 — intervention group
Group type: COMPARATOR
Intervention: Blended control
Number of subjects: 98
Study 33647827 — intervention group
Group type: COMPARATOR
Intervention: Standard control
Number of subjects: 98
Study 33647827 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended cognitive dissonance (with higher in-group identification)
Number of subjects: 98
Study 36064604 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of ABCB5+ mesenchymal stem cells (MSCs)
Number of subjects: 23
Study 34128498 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment (plate fixation with a precontoured distal clavicular plate or a 'hook' plate within 28 days from injury)
Number of subjects: 57
Study 34128498 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment (standard shoulder sling, followed by pendulum or gentle range of motion shoulder exercises)
Number of subjects: 57
Study 34128498 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative treatment
Number of subjects: 57
Study 34128498 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 57
Study 32920032 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine gel
Number of subjects: 120
Study 32920032 — intervention group
Group type: COMPARATOR
Intervention: water soluble gel
Number of subjects: 120
Study 32920032 — intervention group
Group type: EXPERIMENTAL
Intervention: flexible cystoscopy
Number of subjects: 120
Study 32920032 — intervention group
Group type: COMPARATOR
Intervention: rigid cystoscopy
Number of subjects: 120
Study 35768085 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain framing education videos about self-management skills for type 2 diabetes
Number of subjects: 84
Study 35768085 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss framing education videos about self-management skills for type 2 diabetes
Number of subjects: 84
Study 35768085 — intervention group
Group type: COMPARATOR
Intervention: Education with no specific message framing
Number of subjects: 84
Study 35768085 — intervention group
Group type: EXPERIMENTAL
Intervention: Gain framing education videos
Number of subjects: 84
Study 35768085 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss framing education videos
Number of subjects: 84